It is little wonder that some TB vaccine researchers suffer from a rare syndrome that understandably threatens their mental health. Symptoms include frustration, impatience, irritability, seemingly inexplicable rage and, in the least resilient, despair. It is called VJS or Vaccine Jealousy Syndrome** — in 99% of cases associated with the sudden appearance and out of kilter funding of, (in an astoundingly short 12 months), Covid-19 vaccines. Never ones to miss an opportunity, even though they carry the research begging bowl, the TB crew have started leveraging the remarkable scientific advances that produce vaccines with up to 95% efficacy against Covid-19. Even so, researchers say that based on current information it will take up to five years for the top TB vaccine candidate, M72, to complete sufficiently large Phase III trials.